Literature DB >> 8851620

Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis.

D Vermot1, J M Entenza, J Vouillamoz, M P Glauser, P Moreillon.   

Abstract

Clarithromycin is compared with clindamycin for single-dose prophylaxis of streptococcal endocarditis in rats. Human-like kinetics of the two antibiotics prevented endocarditis in animals challenged with both small and large amounts of bacterial inocula. Clarithromycin was marginally superior to clindamycin against small amounts of inocula. Clarithromycin may be considered for endocarditis chemoprophylaxis in human.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8851620      PMCID： PMC163207     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

Authors:  A S Dajani; A L Bisno; K J Chung; D T Durack; M Freed; M A Gerber; A W Karchmer; H D Millard; S Rahimtoola; S T Shulman
Journal:  JAMA       Date:  1990-12-12       Impact factor: 56.272

2.  Gastrointestinal side effects associated with clinidamycin. 1,000 consecutive patients.

Authors:  J E Swartzberg; R M Maresca; J S Remington
Journal:  Arch Intern Med       Date:  1976-08

3.  Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci.

Authors:  U Fluckiger; P Francioli; J Blaser; M P Glauser; P Moreillon
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

4.  Natural history of aortic valve endocarditis in rats.

Authors:  E Héraïef; M P Glauser; L R Freedman
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

5.  Recommendations for endocarditis prophylaxis. The Endocarditis Working Party for Antimicrobial Chemotherapy.

Authors:  N A Simmons
Journal:  J Antimicrob Chemother       Date:  1993-03       Impact factor: 5.790

6.  Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.

Authors:  J M Entenza; M Blatter; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia.

Authors:  G Hall; S A Hedström; A Heimdahl; C E Nord
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

8.  Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial.

Authors:  S Chu; Y Park; C Locke; D S Wilson; J C Cavanaugh
Journal:  J Clin Pharmacol       Date:  1992-01       Impact factor: 3.126

9.  A new type of penicillin resistance of Staphylococcus aureus.

Authors:  L D Sabath; N Wheeler; M Laverdiere; D Blazevic; B J Wilkinson
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

10.  Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS.

Authors:  G Gatti; J Flaherty; J Bubp; J White; M Borin; J Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191
View more
  2 in total

1.  Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.

Authors:  M S Rouse; J M Steckelberg; C M Brandt; R Patel; J M Miro; W R Wilson
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.

Authors:  Philippe Moreillon; Walter R Wilson; Roland Leclercq; José M Entenza
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.